Literature DB >> 26786251

Incidence and survival of adult cancer patients in Taiwan, 2002-2012.

Chun-Ju Chiang1, Wei-Cheng Lo1, Ya-Wen Yang1, San-Lin You2, Chien-Jen Chen3, Mei-Shu Lai4.   

Abstract

BACKGROUND/
PURPOSE: Little is known about the annual changes in cancer incidence and survival that occurred after the establishment of the long-form cancer registry database in Taiwan. Therefore, this study aimed to investigate the updated incidence and stage-specific relative survival rates (RSRs) among adult cancer patients in Taiwan.
METHODS: Cancer incidence data from 2002 to 2012 were collected using the Taiwan Cancer Registry Database. Age-standardized incidence rates, average annual percent changes (AAPCs), and sex ratios were calculated for adults. Five-year stage-specific RSRs were estimated for cases diagnosed between 2004 and 2008 and were followed up to 2013 for major cancers.
RESULTS: The overall age-standardized incidence rates per 100,000 populations increased from 348.39 in 2002 to 401.18 in 2012, and the AAPC was 1.7% (p < 0.05), whereas the male:female ratio was approximately 1:3 during the entire period. Most cancer sites showed a trend of increasing incidence, with the exception of common cancers such as cervix uteri (AAPC = -6.2%, p < 0.05), bladder (AAPC = -2.5%, p < 0.05), stomach (AAPC = -2.4%, p < 0.05), nasopharynx (AAPC = -1.2%, p < 0.05), and liver (AAPC = -1.1%, p < 0.05). The 5-year RSRs for Stage I cancers were greater than 93% for the colon and rectum, female breast, and cervix uteri, whereas RSRs for patients with Stage IV cancers ranged from 2.9% to 38.9%, with patients with liver cancer and those with oral cancer showing the lowest and highest RSRs, respectively.
CONCLUSION: Our study showed increased incidence in most cancers and provided baseline estimates of stage-specific RSRs among the Taiwanese adult population. Continuous surveillance may help politicians to improve health policies and cancer care in Taiwan.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Taiwan; average annual percentage change of incidence; cancer; population-based cancer registry; relative survival

Mesh:

Year:  2016        PMID: 26786251     DOI: 10.1016/j.jfma.2015.10.011

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  87 in total

1.  miR-211 regulates the expression of RRM2 in tumoral metastasis and recurrence in colorectal cancer patients with a k-ras gene mutation.

Authors:  Chiu-Chun Chang; Chun-Che Lin; Chia-Hung Wang; Chi-Chou Huang; Tao-Wei Ke; Po-Li Wei; Ken-Tu Yeh; Kai-Cheng Hsu; Nan-Yung Hsu; Ya-Wen Cheng
Journal:  Oncol Lett       Date:  2018-03-19       Impact factor: 2.967

2.  National Policies Fostering Hospice Care Increased Hospice Utilization and Reduced the Invasiveness of End-of-Life Care for Cancer Patients.

Authors:  Yu-Yun Shao; Emily Han-Chung Hsiue; Chih-Hung Hsu; Chien-An Yao; Ho-Min Chen; Mei-Shu Lai; Ann-Lii Cheng
Journal:  Oncologist       Date:  2017-04-13

3.  Auricular acupressure: reducing side effects of chemotherapy in women with ovarian cancer.

Authors:  Ying Tsao; Debra K Creedy
Journal:  Support Care Cancer       Date:  2019-02-22       Impact factor: 3.603

4.  Multimodal exercise ameliorates exercise responses and body composition in head and neck cancer patients receiving chemotherapy.

Authors:  Chia-Jui Yen; Ching-Hsia Hung; Chung-Lan Kao; Wei-Ming Tsai; Shih-Hung Chan; Hui-Ching Cheng; Wan-Ting Jheng; Yan-Jhen Lu; Kun-Ling Tsai
Journal:  Support Care Cancer       Date:  2019-04-04       Impact factor: 3.603

5.  Good glycaemic control is associated with a better prognosis in breast cancer patients with type 2 diabetes mellitus.

Authors:  Yen-Lin Chang; Wayne Huey-Herng Sheu; Shih-Yi Lin; Wen-Shyong Liou
Journal:  Clin Exp Med       Date:  2018-03-23       Impact factor: 3.984

6.  Epidemiological Trends in Colorectal Cancer in China: An Ecological Study.

Authors:  Jinzhou Zhu; Zhengqi Tan; Kelseanna Hollis-Hansen; Yong Zhang; Chaohui Yu; Youming Li
Journal:  Dig Dis Sci       Date:  2016-10-31       Impact factor: 3.199

Review 7.  The frontline of esophageal cancer treatment: questions to be asked and answered.

Authors:  Cheng-Che Tu; Po-Kuei Hsu
Journal:  Ann Transl Med       Date:  2018-02

8.  Survival of Patients with Lung Cancer in the Setting of Liver Cirrhosis: A Multicenter Propensity Score Matching Study.

Authors:  Ming-Shian Lu; Hung-I Lu; Tzu-Ping Chen; Che-Chia Chang; Tsung-Ming Yang; Miao-Fen Chen
Journal:  Cancer Manag Res       Date:  2021-06-01       Impact factor: 3.989

9.  Doctor-Patient Cancer Screening Communications among Church-based Chinese Adults - The Role of Caregiver Experience and Family History.

Authors:  Su-I Hou
Journal:  Asian Pac J Cancer Prev       Date:  2021-01-01

10.  Single-Agent Versus Double-Agent Chemotherapy in Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma: Prospective, Randomized, Multicenter Phase II Clinical Trial.

Authors:  Zhenhuan Zhao; Yixue Wen; Dongbiao Liao; Jidong Miao; Yan Gui; Hongwei Cai; Yang Chen; Min Wei; Qiang Jia; Honggang Tian; Mingqiang Sun; Yu Zhang; Gang Feng; Xiaobo Du
Journal:  Oncologist       Date:  2020-09-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.